Publication Details

AFRICAN RESEARCH NEXUS

SHINING A SPOTLIGHT ON AFRICAN RESEARCH

medicine

GeneXpert MTB/RIF version g4 for identification of rifampin-resistant tuberculosis in a programmatic setting

Journal of Clinical Microbiology, Volume 52, No. 2, Year 2014

A recent Cochrane review estimated GeneXpert MTB/RIF specificity for rifampin resistance as 98% (95% confidence interval [CI], 97 to 99), based on results from earlier test versions. The measured positive predictive value of the new generation test from programmatic implementation in Cape Town, South Africa, was 99.5% (95% CI, 98.5 to 100), confirming excellent specificity. Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Statistics
Citations: 35
Authors: 5
Affiliations: 3
Identifiers
Doi: 10.1128/JCM.02517-13
ISSN: 00951137
e-ISSN: 1098660X
Study Locations
South Africa

Disclaimer

All information and calculations provided are based on our current indexed publications and may change as more data is collected.

African Research Nexus

The African Research Nexus is a visionary initiative that seeks to increase the visibility of African Researchers and Institutions. We are a dynamic hub designed to transform the African research landscape and amplify the voices of our continent’s brightest minds.

Useful Links

ABOUT US
PROFILES
Authors Directory
AI Digest
CONTACT US

Subscribe Now
Don’t miss our future updates!

Follow Us